Metabolic Disorders

  • Gerald S. Golden
Part of the Topics in Pediatrics book series (TIPE)

Abstract

Metabolic disorders are those conditions in which there is an abnormality in one or more metabolic pathways, producing disease or impaired function. The central nervous system can be primarily involved by such a process or affected secondary to a severe generalized metabolic disturbance. The great majority of these disorders are hereditary; most are transmitted by autosomal recessive mechanisms.

Keywords

Migraine Folic Acid Galactose Cataract Hypothyroidism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., Goldstein, J. I.., and Brown, M. S., 1983, The Metabolic Basis of Inherited Disease, 5th cd., McGraw -Hill, New York.Google Scholar
  2. 2.
    Therrel, B. I.., Brown, L. O., Dziuk, P. E., and Peter, W. P., 1983, The Texas Newborn Screening Program, Texas Med. 79: 44–46.Google Scholar
  3. 3.
    Koch, R., Azen, C. G., Friedman, E. G., and Williamson, M. L., 1982, Preliminary report on the effects of diet discontinuation in PKU, J. Pediatr. 100: 870–875.PubMedCrossRefGoogle Scholar
  4. 4.
    Levy, H. L., Kaplan, G. N., and Erickson, A. M., 1982, Comparison of treated and untreated pregnancies in a mother with phenylketonuria, J. Pediatr. 100: 876–880.PubMedCrossRefGoogle Scholar
  5. 5.
    Berlow, S., 1980, Progress in phenylketonuria: Defects in the metabolism of biopterin, Pediatrics 65: 837–839.PubMedGoogle Scholar
  6. 6.
    Hudak, M. L., Jones, M. D., and Brusilow, S. W., 1985, Differentiation of transient hyperammonemia of the newborn and urea cycle enzyme defects by clinical presentation, f. Pediatr. 107: 712–719.CrossRefGoogle Scholar
  7. 7.
    Msall, M., Batshaw, M. I.., Suss, R., Brusilaw, S. W., and Mellits, E. D., 1984, Neurologic outcome in children with inborn errors of urea synthesis, N. Engl. J. Med. 310: 1500–1505.PubMedCrossRefGoogle Scholar
  8. 8.
    Rebouche, C. J., and Engel, A. G., 1983, Carnitine metabolism and deficiency syndromes, Mayo Clin. Proc. 58: 533–540.PubMedGoogle Scholar
  9. 9.
    Wolf, B., Heard, G. S., Weissbecker, K. A., McVoy, J. R. S., Grier, R. E., and Leshner, R. T., 1985, Biotinidase deficiency: Initial clinical features and rapid diagnosis, Ann. Neurol. 18: 614–617.PubMedCrossRefGoogle Scholar
  10. 10.
    Zoghbi, H. Y., Percy, A. K., Glaze, D. G., Butler, I. J., and Riccardi, V. M., 1985, Reduction of biogenic amine levels in the Rett syndrome, N. Engl. J. Med. 313: 921–924.PubMedCrossRefGoogle Scholar

Additional Reading

  1. Horwitz, A., 1979, The mucopolysaccharidoses: Clinical and biochemical correlations, Am. J. Ment. Def. 84: 113–123.Google Scholar
  2. Koch, R. (ed.), 1981, Urea cycle symposium, Pediatrics 68:271–279, 446–462.PubMedGoogle Scholar
  3. Rosenberg, R. N., 1981, Biochemical genetics of neurologic disease, N. Engl. J. Med. 305: 1181–1193.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1987

Authors and Affiliations

  • Gerald S. Golden
    • 1
  1. 1.Department of Neurology, The Health Science CenterUniversity of Tennessee, MemphisMemphisUSA

Personalised recommendations